JP2021532818A5 - - Google Patents
Info
- Publication number
- JP2021532818A5 JP2021532818A5 JP2021506562A JP2021506562A JP2021532818A5 JP 2021532818 A5 JP2021532818 A5 JP 2021532818A5 JP 2021506562 A JP2021506562 A JP 2021506562A JP 2021506562 A JP2021506562 A JP 2021506562A JP 2021532818 A5 JP2021532818 A5 JP 2021532818A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- hapten
- car
- antigen receptor
- chimeric antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024108743A JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862714928P | 2018-08-06 | 2018-08-06 | |
| US62/714,928 | 2018-08-06 | ||
| PCT/US2019/044981 WO2020033272A1 (en) | 2018-08-06 | 2019-08-02 | Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024108743A Division JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532818A JP2021532818A (ja) | 2021-12-02 |
| JP2021532818A5 true JP2021532818A5 (https=) | 2022-08-09 |
Family
ID=69415147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506562A Pending JP2021532818A (ja) | 2018-08-06 | 2019-08-02 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
| JP2024108743A Pending JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024108743A Pending JP2024138364A (ja) | 2018-08-06 | 2024-07-05 | ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210317407A1 (https=) |
| EP (1) | EP3833363A4 (https=) |
| JP (2) | JP2021532818A (https=) |
| KR (1) | KR20210074274A (https=) |
| CN (1) | CN112789051A (https=) |
| AU (1) | AU2019319674A1 (https=) |
| CA (1) | CA3108778A1 (https=) |
| WO (1) | WO2020033272A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| US10611837B2 (en) | 2014-04-10 | 2020-04-07 | Seattle Children's Hospital | Transgene genetic tags and methods of use |
| EP3234120B1 (en) | 2014-12-15 | 2025-09-03 | The Regents of the University of California | Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing |
| FI3240805T3 (fi) | 2014-12-15 | 2025-02-17 | Univ California | Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori |
| PL3368571T3 (pl) | 2015-10-30 | 2023-05-02 | The Regents Of The University Of California | Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| US11649288B2 (en) | 2017-02-07 | 2023-05-16 | Seattle Children's Hospital | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| US12312416B2 (en) * | 2018-02-06 | 2025-05-27 | Seattle Children's Hospital | Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| CA3096458A1 (en) | 2018-04-12 | 2019-10-17 | Umoja Biopharma, Inc. | Viral vectors and packaging cell lines |
| CN115397440A (zh) * | 2020-02-04 | 2022-11-25 | 西雅图儿童医院（Dba西雅图儿童研究所） | 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物 |
| CN115210252A (zh) | 2020-02-04 | 2022-10-18 | 西雅图儿童医院（Dba西雅图儿童研究所） | 抗二硝基苯酚的嵌合抗原受体 |
| WO2021189008A1 (en) | 2020-03-20 | 2021-09-23 | Lyell Immunopharma, Inc. | Novel recombinant cell surface markers |
| WO2021223359A1 (en) * | 2020-05-06 | 2021-11-11 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
| CN111735952B (zh) * | 2020-06-04 | 2023-07-11 | 北京勤邦科技股份有限公司 | 一种检测六氯苯的试纸条及方法 |
| CA3186029A1 (en) * | 2020-06-08 | 2021-12-16 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Anti-cd171 chimeric antigen receptors |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| CN114019166B (zh) * | 2021-09-27 | 2024-02-27 | 浙江省食品药品检验研究院 | 一种检测龙葵素的试纸条及其应用 |
| EP4430068A4 (en) * | 2021-11-10 | 2025-11-19 | Outpace Bio Inc | CHIMER ANTIGEN RECEPTORS |
| CN119775406B (zh) * | 2025-01-22 | 2025-11-25 | 北京赛科希德科技股份有限公司 | 纤溶酶降解产物d-二聚体抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004113062A (ja) * | 2002-09-25 | 2004-04-15 | Teruyuki Nagamune | キメラ受容体を有する動物細胞とその利用 |
| WO2016168769A1 (en) * | 2015-04-15 | 2016-10-20 | The California Institute For Biomedical Research | Chimeric receptor t cell switches for her2 |
| CN109789092A (zh) * | 2016-07-13 | 2019-05-21 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
| CN110381989A (zh) * | 2016-12-21 | 2019-10-25 | 丹麦技术大学 | 用于免疫细胞操作的抗原呈递支架 |
| KR20260026092A (ko) * | 2017-09-19 | 2026-02-25 | 메사추세츠 인스티튜트 오브 테크놀로지 | 키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도 |
-
2019
- 2019-08-02 KR KR1020217006444A patent/KR20210074274A/ko active Pending
- 2019-08-02 CA CA3108778A patent/CA3108778A1/en active Pending
- 2019-08-02 AU AU2019319674A patent/AU2019319674A1/en active Pending
- 2019-08-02 WO PCT/US2019/044981 patent/WO2020033272A1/en not_active Ceased
- 2019-08-02 CN CN201980065406.9A patent/CN112789051A/zh active Pending
- 2019-08-02 EP EP19846044.6A patent/EP3833363A4/en active Pending
- 2019-08-02 US US17/265,484 patent/US20210317407A1/en active Pending
- 2019-08-02 JP JP2021506562A patent/JP2021532818A/ja active Pending
-
2024
- 2024-07-05 JP JP2024108743A patent/JP2024138364A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532818A5 (https=) | ||
| AU2021221785B2 (en) | Engineered gamma delta T-cells | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| TWI788781B (zh) | 新型改造t細胞受體及其免疫治療 | |
| KR20210074274A (ko) | 합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물 | |
| JP2020188789A (ja) | 免疫療法のためのナノ粒子組成物及び方法 | |
| CN111936518A (zh) | 对fl-ple标记的肿瘤表现出最佳的t细胞功能的荧光素特异性car | |
| CN110072533A (zh) | 选择性扩增γδT细胞群的方法及其组合物 | |
| CN109072195A (zh) | 具有增强功效的免疫效应细胞疗法 | |
| CN109121413A (zh) | 使用靶向核酸纳米载体编程治疗性细胞的组合物和方法 | |
| JP2006506954A (ja) | Ｔｃｒ及びｔｉｒｃ７に結合する新規な抗体、並びに治療及び診断におけるその使用 | |
| CN115397440A (zh) | 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物 | |
| JP2023500338A5 (https=) | ||
| JP7785696B2 (ja) | 操作されたｔ細胞受容体および使用の方法 | |
| US20230009275A1 (en) | Methods for expanding gamma delta t-cell populations with multivalent agents and compositions thereof | |
| AU2018370120C1 (en) | Methods for selective expansion of d3 yd T-cell populations and compositions thereof | |
| JP2021045150A5 (https=) | ||
| HK40109798A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| HK40097671A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| HK40097672A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| JP2024527963A5 (https=) | ||
| WO2025252993A1 (en) | Chimeric antigen receptor targeting glioma-associated antigens | |
| HK40113193A (zh) | 靶向ndc80抗原的肽和经改造t细胞受体及使用方法 | |
| CN118265721A (zh) | 靶向ndc80抗原的肽和经改造t细胞受体及使用方法 | |
| CN115838432A (zh) | 一种靶向调控抗原特异性t细胞的融合蛋白及应用 |